MIMETAS
Jacquelien ten Dam currently serves as CFO at MIMETAS since September 2019 and holds a position on the Board of Directors for Mauna Kea Technologies since December 2020. MIMETAS specializes in organ-on-a-chip technology, while Mauna Kea Technologies is noted for its advancements in medical devices aimed at improving cancer diagnostics. Previously, Jacquelien was involved with Picnic supermarkets and held various roles at Kempen & Co, including Vice President of Corporate Finance in the Life Sciences sector. Early career experiences include a brief secondment at Dr. Reddy's Laboratories and teaching at Stichting Studiebegeleiding Leiden. Jacquelien holds an MSc in Biomedical Sciences from Leiden University and has pursued further education at UCLA and the Amsterdam Institute of Finance.
This person is not in any offices
MIMETAS
3 followers
MIMETAS - The Organ-on-a-Chip Company offers OrganoPlates and develops human tissue and disease models for tomorrow’s medicines, chemicals and food.